Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

被引:51
作者
Sepehr, A
Tanière, P
Martel-Planche, G
Zia'ee, AA
Rastgar-Jazii, F
Yazdanbod, M
Etemad-Moghadam, G
Kamangar, F
Saidi, F
Hainaut, P
机构
[1] IARC, Grp Mol Carcinogenesis, F-69008 Lyon, France
[2] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[3] NRCGEB, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Surg, Tehran, Iran
[5] Iran Mehr Hosp, Dept Pathol, Tehran, Iran
[6] Iran Mehr Hosp, Dept Surg, Tehran, Iran
[7] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
esophagus; neoplasms; Iran; p53; COX-2;
D O I
10.1038/sj.onc.1204912
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extremely high rates of squamous cell carcinoma of the esophagus (SCCE), are observed in Iran,, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic alterations, in SCCE,: TP53: mutations are the most frequent, vary among populations, and may provide clues on etiological mechanisms. We have analysed mutations in TP53 (exons 5-8): in 98 SCCE from Iran by temporal temperature get electrophoresis and direct sequencing. We found 58, mutations, in 49 patients, (50%,), with a high prevalence of C to T transitions at CpG dinucleotides (29.3%). The TP53 mutation pattern in Iran was significantly different from that observed in SCCEs from high incidence areas of China and Western Europe (P=0.007)., Moreover, the prevalence of mutations at A:T base pairs, (transitions and transversions) was higher in men than in women (38.7%, vs 11.1%, P=0.033). COX-2 overexpression was, detected in 69% of the cases evaluated (24/35), without significant association with TP53, mutation. Accumulation of nitrotyrosine, a marker of protein damage by excess, levels of nitric oxide, was observed in tumor cells, in six of 16 cases analysed. These results are consistent with the hypothesis that several factors are involved in TP53 mutagenesis, in Iran., These factors include a baseline of chronic inflammatory stress, which may have a multiplicative impact on the sensitivity of esophageal cells to exogenous factors of risk.
引用
收藏
页码:7368 / 7374
页数:7
相关论文
共 50 条
  • [31] TP53 mutations in human meningiomas
    Verheijen, FM
    Sprong, M
    Kloosterman, JME
    Blaauw, G
    Thijssen, JHH
    Blankenstein, MA
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (01) : 42 - 48
  • [32] Polymorphic TP53BP1 and TP53 gene interactions associated with risk of squamous cell carcinoma of the head and neck
    Chen, Kexin
    Hu, Zhibin
    Wang, Li-E
    Zhang, Wei
    Ei-Naggar, Adel K.
    Sturgis, Erich M.
    Wei, Qingyi
    CLINICAL CANCER RESEARCH, 2007, 13 (14) : 4300 - 4305
  • [33] Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma
    Todorova, Teodora A.
    Jordanov, Stanislav H.
    Stancheva, Gergana S.
    Chalakov, Ivan J.
    Melnicharov, Mincho B.
    Kunev, Kuncho V.
    Mitev, Vanio I.
    Kaneva, Radka P.
    Goranova, Teodora E.
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (02) : 413 - 421
  • [34] Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: Identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection
    Long, Jiang
    Wang, Yan
    Li, Man
    Tong, Wei-Min
    Jia, Ji-Dong
    Huang, Jian
    ONCOLOGY REPORTS, 2013, 30 (01) : 119 - 124
  • [35] TP53 Y220C Is a Hotspot Mutation in Oropharyngeal Squamous Cell Carcinoma
    van Kempen, Pauline M. W.
    Verdam, Froukje J.
    de Poel, Eyleen
    Braunius, Weibel W.
    de Weger, Roel A.
    van Es, Robert J. J.
    Grolman, Wilko
    Willems, Stefan M.
    PATHOBIOLOGY, 2015, 82 (01) : 21 - 27
  • [36] Expression of TP53 in oral squamous cell carcinoma and its correlation with adverse histopathological features
    Giri, Ranjana
    Hota, Subhransu Kumar
    Sahu, Subrat Kumar
    Senapati, Urmila
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (02) : 278 - 282
  • [37] Associated microsatellite alterations in mitochondrial DNA and in TP53 in thoracic esophageal squamous cell carcinoma
    Len, Chen-Sung
    Wang, Liang-Shun
    Chang, Shi-Chuan
    Chou, Teh-Ying
    Hsu, Wen-Hu
    Liu, Chin-San
    Lee, Mau-Hwa
    Chung, Ming-Yi
    Wei, Yau-Huei
    ONCOLOGY REPORTS, 2012, 28 (01) : 69 - 76
  • [38] Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
    Li, Xuerui
    Chen, Xiaoqing
    Wen, Lingzhu
    Wang, Yulei
    Chen, Bo
    Xue, Yunlian
    Guo, Liping
    Liao, Ning
    THORACIC CANCER, 2020, 11 (07) : 1861 - 1868
  • [39] Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population
    Wang, Zhen
    Xia, Rong-Hui
    Ye, Dong-Xia
    Li, Jiang
    PLOS ONE, 2016, 11 (10):
  • [40] HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
    D Meulendijks
    N B Tomasoa
    L Dewit
    P H M Smits
    R Bakker
    M-L F van Velthuysen
    E H Rosenberg
    J H Beijnen
    J H M Schellens
    A Cats
    British Journal of Cancer, 2015, 112 : 1358 - 1366